Search Results - Xiang-Hui Fu

Meplazumab, a CD147 antibody, for severe COVID-19: a double-blind, randomized, placebo-controlled, phase 3 clinical trial by Huijie Bian, Liang Chen, Zheng Zhang, Ai-Dong Wen, Zhao-Hui Zheng, Li-Qiang Song, Meng-Ying Yao, Ying-Xia Liu, Xi-Jing Zhang, Hong-Lin Dong, Jian-Qi Lian, Lei Pan, Yu Liu, Xing Gu, Hui Zhao, Jing-Wen Wang, Qing-Yi Wang, Kui Zhang, Jun-Feng Jia, Rong-Hua Xie, Xing Luo, Xiang-Hui Fu, Yan-Yan Jia, Jun-Na Hou, Qiu-Yue Tan, Xiao-Xia Chen, Liu-Qing Yang, Yuan-Long Lin, Xiao-Xia Wang, Lei Zhang, Qin-Jing Zeng, Wen-Jie Li, Rui-Xuan Wang, Yang Zhang, Xiu-Xuan Sun, Bin Wang, Xu Yang, Jian-Li Jiang, Ling Li, Jiao Wu, Xiang-Min Yang, Hai Zhang, Ying Shi, Xiao-Chun Chen, Hao Tang, Hong-Wei Shi, Shuang-Shuang Liu, Yong Yang, Tian-Yi Yang, Ding Wei, Zhi-Nan Chen, Ping Zhu

Get full text